Panome Bio, a trusted CROaccess partner, offers a global metabolomics platform that delivers the broadest view of polar and lipid metabolites from endogenous and exogenous sources — including food, drugs, and environmental exposures. Using multiple complementary LC-MS assays, Panome Bio generates high-quality untargeted metabolomics data to provide an unbiased and comprehensive view of metabolism.

Through advanced computational pipelines, Panome Bio removes noise and irrelevant signals from raw data, normalizes across samples, and applies rigorous statistical and machine learning methods to ensure confident metabolite identification.

Panome Bio’s Next-Generation Metabolomics® technology empowers researchers to explore biology at unprecedented depth — ideal for biomarker development, epidemiology, patient stratification, drug mechanism studies, longitudinal analyses, and more.

Advantages of Panome Bio’s Next-Generation Metabolomics Platform

Covers the widest range of metabolites — from polar compounds to lipids

Not limited by predefined panels or libraries

Utilizes 4 complementary LC-MS assays for maximum chemical coverage

Proprietary computational pipeline matches metabolites to a database of 175,000+ compounds

Removes redundant and non-biological signals for confident, high-quality results

Fast turnaround — data delivered in as little as 4 weeks

Supports diverse applications from biomarker discovery to population health

Sample Requirements

Works with multiple sample types and species

Requires only 50 µL biofluid, 2 mg tissue, or 1 million cells

Clear sample collection, storage, and shipping guidelines provided

Samples should be flash frozen immediately after collection to preserve metabolic state

Now Featuring – Dried Blood Spot (DBS) Analysis

Panome Bio’s Next-Generation Metabolomics platform now supports Dried Blood Spot (DBS) sampling — a minimally invasive, low-volume, and highly stable method ideal for field, clinical, and population studies. DBS sampling offers room-temperature stability, simplified logistics, and reliable quantification across a broad range of metabolites.

Unlock a new dimension of metabolic insight with Panome Bio’s Next-Generation Metabolomics®, available exclusively through CROaccess.